Relapsing demyelinating CNS disease in a Korean pediatric population: Multiple sclerosis versus neuromyelitis optica

Multiple Sclerosis Journal

Volumn 17, Issue 1, 2011, Pages 67-73

  Lim, Byung Chan ^a   Hwang, Hee ^a   Kim, Ki Joong ^a   Hwang, Yong Seung ^a   Cheon, Jung Eun ^b   Kim, In One ^b   Kim, Ho Jin ^c   Chae, Jong Hee ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

Korea; multiple sclerosis; neuromyelitis optica; optic nerve; spinal cord

Indexed keywords

AQUAPORIN 4 ANTIBODY; IMMUNOGLOBULIN G; INTERFERON BETA SERINE; LIVER ENZYME; OLIGOCLONAL BAND; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANEMIA; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE DURATION; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; ENZYME BLOOD LEVEL; FEMALE; HEMATURIA; HUMAN; ISOELECTRIC FOCUSING; KIDNEY BIOPSY; KOREA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; PNEUMONIA; PRESCHOOL CHILD; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SILVER STAINING; SPINAL NERVE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE;

EID: 78650984594     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510382685     Document Type: Article

References (30)

1. Banwell B., Ghezzi A., Bar-Or A., Mikaeloff Y. and Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies future directions. Lancet Neurol 2007 ; 6: 887-902.
2. Ghezzi A., Deplano V., Faroni J., Grasso MG, Liguori M., Marrosu G., et al. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997 ; 3: 43-46.
3. Simone IL, Carrara D., Tortorella C., Liguori M., Lepore V., Pellegrini F., et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002 ; 59: 1922-1928.
4. Mikaeloff Y., Caridade G., Assi S., Suissa S. and Tardieu M. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics 2006 ; 118: 1133-1139.
5. Deryck O., Ketelaer P. and Dubois B. Clinical characteristics and long-term prognosis in early-onset multiple sclerosis. J Neurol 2006 ; 253: 720-723.
6. Graber DJ, Levy M., Kerr D. and Wade WF Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008 ; 5: 22.
7. Banwell B., Tenembaum S., Lennon VA, Ursell E., Kennedy J., Bar-Or A., et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 2008 ; 70: 344-352.
8. McKeon A., Lennon VA, Lotze T., Tenenbaum S., Ness JM, Rensel M., et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008 ; 71: 93-100.
9. Lotze TE, Northrop JL, Hutton GJ, Ross B., Schiffman JS and Hunter JV Spectrum of pediatric neuromyelitis optica. Pediatrics 2008 ; 122: e1039-1047.
10. Krupp LB, Banwell B. and Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007 ; 68: S7-12.
11. Weng WC, Yang CC, Yu TW, Shen YZ and Lee WT Multiple sclerosis with childhood onset: report of 21 cases in Taiwan. Pediatr Neurol 2006 ; 35: 327-334.
12. Shiraishi K., Higuchi Y., Ozawa K., Hao Q. and Saida T. Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan. Brain Dev 2005 ; 27: 224-227.
13. Tanaka K., Tani T., Tanaka M., Saida T., Idezuka J., Yamazaki M., et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007 ; 13: 850-855. (Pubitemid 351540855)
14. McDonald WI, Compston A., Edan G., Goodkin D., Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
15. Alper G., Heyman R. and Wang L. Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol 2009 ; 51: 480-486.
16. Neuteboom RF, Boon M., Catsman Berrevoets CE, Vles JS, Gooskens RH, Stroink H., et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008 ; 71: 967-973.
17. Dale RC and Pillai SC Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions. Dev Med Child Neurol 2007 ; 49: 887-893.
18. Ness JM, Chabas D., Sadovnick AD, Pohl D., Banwell B. and Weinstock-Guttman B. Clinical features of children and adolescents with multiple sclerosis. Neurology 2007 ; 68: S37-45.
19. Freedman MS, Thompson EJ, Deisenhammer F., Giovannoni G., Grimsley G., Keir G., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 2005 ; 62: 865-870.
20. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003 ; 2: 117-127.
21. Mikaeloff Y., Adamsbaum C., Husson B., Vallee L., Ponsot G., Confavreux C., et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004 ; 127: 1942-1947.
22. Hahn CD, Shroff MM, Blaser SI and Banwell BL MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology 2004 ; 62: 806-808.
23. Chong HT, Kira J., Tsai CP, Ong B., Li PC, Kermode A., et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler 2009 ; 15: 887-888.
24. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ and Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007 ; 6: 805-815.
25. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112. (Pubitemid 39626806)
26. Nakashima I., Fujihara K., Miyazawa I., Misu T., Narikawa K., Nakamura M., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006 ; 77: 1073-1075.
27. Matsuoka T., Matsushita T., Kawano Y., Osoegawa M., Ochi H., Ishizu T., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007 ; 130: 1206-1223.
28. Wingerchuk DM Neuromyelitis optica. Adv Neurol 2006 ; 98: 319-333.
29. Tanaka M., Tanaka K. and Komori M. Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol 2009 ; 62: 167-170.
30. Matsushita T., Isobe N., Matsuoka T., Shi N., Kawano Y., Wu XM, et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 2009 ; 15: 834-847.